The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of sirolimus in combination with metronomic chemotherapy (CHOAnome) in children with recurrent and/or refractory solid and CNS tumors.
 
Thomas Cash
Honoraria - EUSA Pharma
Consulting or Advisory Role - Y-mAbs Therapeutics
Research Funding - Celgene; Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly; United Therapeutics
 
Dolly Aguilera
No Relationships to Disclose
 
Kevin Fate Ginn
No Relationships to Disclose
 
Lindsey M. Hoffman
No Relationships to Disclose
 
Rohali Keesari
No Relationships to Disclose
 
William C. Petersen
No Relationships to Disclose
 
Emi H. Caywood
No Relationships to Disclose
 
Muna Qayed
No Relationships to Disclose
 
Erin Connelly
No Relationships to Disclose
 
Sarah S. Milla
No Relationships to Disclose
 
Robert C. Castellino
No Relationships to Disclose
 
Jason Fangusaro
No Relationships to Disclose
 
Tobey J. MacDonald
No Relationships to Disclose
 
Cynthia Wetmore
No Relationships to Disclose
 
Howard Katzenstein
No Relationships to Disclose